Xenon Pharmaceuticals Inc (XENE)
40.01
+0.13
(+0.33%)
USD |
NASDAQ |
Apr 22, 16:00
39.99
-0.02
(-0.05%)
After-Hours: 20:00
Xenon Pharmaceuticals Cash and Short Term Investments (Quarterly): 638.08M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 638.08M |
| September 30, 2023 | 526.67M |
| June 30, 2023 | 539.60M |
| March 31, 2023 | 527.04M |
| December 31, 2022 | 592.09M |
| September 30, 2022 | 638.18M |
| June 30, 2022 | 788.24M |
| March 31, 2022 | 537.94M |
| December 31, 2021 | 551.77M |
| September 30, 2021 | 249.62M |
| June 30, 2021 | 260.52M |
| March 31, 2021 | 274.70M |
| December 31, 2020 | 177.00M |
| September 30, 2020 | 190.93M |
| June 30, 2020 | 202.75M |
| March 31, 2020 | 229.67M |
| December 31, 2019 | 141.36M |
| September 30, 2019 | 94.60M |
| June 30, 2019 | 101.80M |
| March 31, 2019 | 110.43M |
| Date | Value |
|---|---|
| December 31, 2018 | 119.31M |
| September 30, 2018 | 127.13M |
| June 30, 2018 | 63.27M |
| March 31, 2018 | 35.08M |
| December 31, 2017 | 43.67M |
| September 30, 2017 | 43.77M |
| June 30, 2017 | 51.70M |
| March 31, 2017 | 58.03M |
| December 31, 2016 | 64.15M |
| September 30, 2016 | 69.49M |
| June 30, 2016 | 50.74M |
| March 31, 2016 | 56.06M |
| December 31, 2015 | 58.65M |
| September 30, 2015 | 65.47M |
| June 30, 2015 | 73.70M |
| March 31, 2015 | 75.38M |
| December 31, 2014 | 84.04M |
| September 30, 2014 | 47.94M |
| June 30, 2014 | 44.71M |
| December 31, 2013 | 49.28M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
94.60M
Minimum
Sep 2019
788.24M
Maximum
Jun 2022
382.24M
Average
274.70M
Median
Mar 2021
Cash and Short Term Investments (Quarterly) Benchmarks
| Acasti Pharma Inc | 25.11M |
| Aurinia Pharmaceuticals Inc | 350.49M |
| Edesa Biotech Inc | 4.268M |
| Lexaria Bioscience Corp | 4.793M |
| ESSA Pharma Inc | 142.12M |